Exogenous NO therapy for the treatment and prevention of atherosclerosis

T Gori - International Journal of Molecular Sciences, 2020 - mdpi.com
Amyl nitrite was introduced in 1867 as the first molecule of a new class of agents for the
treatment of angina pectoris. In the following 150 years, the nitric oxide pathway has been …

Nitric oxide in atherosclerosis

EA Rekka, MC Chrysselis - Mini Reviews in Medicinal …, 2002 - ingentaconnect.com
NO is produced endogenously from L-arginine by NOSs. Among its multiple activities, the
homeostatic control of the vascular endothelium is crucial for atherosclerosis, a pathogenic …

Novel agents targeting nitric oxide

AM Kampoli, D Tousoulis, C Tentolouris… - Current Vascular …, 2012 - ingentaconnect.com
Nitric oxide (NO) is a soluble gas continuously synthesized from the amino acid L-arginine in
endothelial cells by the constitutive calcium-calmodulin-dependent enzyme nitric oxide …

Vasoprotection by nitric oxide: mechanisms and therapeutic potential

MT Gewaltig, G Kojda - Cardiovascular research, 2002 - academic.oup.com
Endothelial production of nitric oxide (nitrogen monoxide, NO) has become a major research
area in vascular biology. Some of the most important effects that NO exerts in the vascular …

[引用][C] Preface to this special journal issue on nitric oxide chemistry and biology

LJ Ignarro - Archives of pharmacal research, 2009 - Springer
The field of nitric oxide (NO) biomedical research started in the 1970s with the observations
that the chemically unstable gas, NO, could activate cytosolic guanylate cyclase to stimulate …

The impact of nitric oxide in cardiovascular medicine: untapped potential utility

CJ Pepine - The American journal of medicine, 2009 - Elsevier
The structural integrity and functional activity of the endothelium play an important role in
atherogenesis and related adverse outcomes. Cardiovascular disease risk conditions …

Nitric oxide and atherosclerosis

C Napoli, LJ Ignarro - Nitric oxide, 2001 - Elsevier
Endothelial dysfunction has been shown in a wide range of vascular desorders including
atherosclerosis and related diseases. Here, we examine and address the complex …

The emerging role of nitrite as an endogenous modulator and therapeutic agent of cardiovascular function

B Tota, AM Quintieri, T Angelone - Current medicinal chemistry, 2010 - ingentaconnect.com
Recently, the circulating anion nitrite (NO2¯), the largest physiological reservoir of nitric
oxide (NO) in the body, has revealed itself as a signalling molecule mediating numerous …

Nitric oxide—biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis

MW Radomski, E Salas - Atherosclerosis, 1995 - Elsevier
Nitric oxide (NO) is generated from l-arginine by the family of isoenzymes called NO
synthases (NOS). Gene cloning has identified neuronal, endothelial and cytokine-inducible …

Nitric oxide therapies in vascular diseases

EM Kurowska - Current pharmaceutical design, 2002 - ingentaconnect.com
Endothelial dysfunction defined as the impaired ability of vascular endothelium to stimulate
vasodilation plays a key role in the development of atherosclerosis and in various …